Review
Patient Reported Outcome Measures (PROMs) in Sarcoidosis
Abstract 317 | PDF Downloads 238 | DOI https://doi.org/10.36141/svdld.v34i1.5760Page 2-17
Original Articles: Clinical Research
A web-based registry for patients with sarcoidosis
Abstract 129 | PDF Downloads 135 | DOI https://doi.org/10.36141/svdld.v34i1.5129Page 26-34
Body Mass Index and Arterial Blood Oxygenation as Prognostic Factors in Patients with Idiopathic Pleuroparenchymal fibroelastosis
Abstract 278 | PDF Downloads 138 | DOI https://doi.org/10.36141/svdld.v34i1.5172Page 35-40
The clinical value of serum soluble interleukin-2 receptor in pulmonary sarcoidosis
Abstract 327 | PDF Downloads 87 | DOI https://doi.org/10.36141/svdld.v34i1.5045Page 41-47
Clinical and molecular features of rapidly progressive chronic hypersensitivity pneumonitis
Abstract 363 | PDF Downloads 191 | DOI https://doi.org/10.36141/svdld.v34i1.5388Page 48-57
Ventilatory disturbances in patients with intrathoracic sarcoidosis – a study from a functional and morphological perspective
Abstract 226 | PDF Downloads 92 | DOI https://doi.org/10.36141/svdld.v34i1.5134Page 58-67
Evaluation of choroidal thickness, retinal vascular caliber, and nerve fiber layer thickness in idiopathic interstitial pneumonia
Abstract 165 | PDF Downloads 105 | DOI https://doi.org/10.36141/svdld.v34i1.5392Page 68-73
Efficacy and safety of TNF antagonists in ocular sarcoidosis: data from the French registry STAT
Abstract 159 | PDF Downloads 86 | DOI https://doi.org/10.36141/svdld.v34i1.5368Page 74-80
Case Reports
Sarcoidosis and Adrenal Angiomyolipoma – a rare tumor and a rarer coincidence
Abstract 158 | PDF Downloads 115 | DOI https://doi.org/10.36141/svdld.v34i1.4506Page 81-84
Temporary remission of autoimmune pulmonary alveolar proteinosis after infectious episodes
Abstract 137 | PDF Downloads 77 | DOI https://doi.org/10.36141/svdld.v34i1.5086Page 85-90
Pirfenidone for primary Sjögren’s syndrome-related fibrotic interstitial pneumonia
Abstract 130 | PDF Downloads 83 | DOI https://doi.org/10.36141/svdld.v34i1.5091Page 91-96
Letter to Editor
CA 15.3: a marker of disease activity in sarcoidosis
Abstract 121 | PDF Downloads 143 | DOI https://doi.org/10.36141/svdld.v34i1.4786Page 100-101